Bionaturis Group (ticker BNT), a partner of reference for animal health products development, has announced that Mr Victor Infante, CEO of the group, will attend the European Animal Health Investment Forum, held in London. This event, considered one of the most important ones in Europe in Animal Health, will be celebrated next February, 10-11th. The event features networking opportunities with high-profile attendess including investors, c-level excecutives from both multinational and emerging companies, academia, etc..

The matrix company of the Group, Bionaturis, is positioned as a partner of choice for outstanding developments of animal health products, including biological vaccines and drugs, medical feed additives, cosmeceuticals for pets, among others.

About Bionaturis

Bionaturis Group offers cutting-edge biotechnological drugs and services for human and animal health. Considered an international benchmark in animal health products development, the biotechnological Group that envisions a global access to health is listed on the Spanish stock exchange for SMEs (ticker BNT).